Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,542,881
-$3,892,155 QoQ
Shares Held
316,673
-42.7% QoQ
Ownership
0.319%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. SPRY ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in SPRY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,542,881 | 316,673 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,435,036 | 552,364 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $7,039,159 | 700,414 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,694,096 | 383,616 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,566,824 | 442,514 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,563,958 | 432,603 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $9,260,017 | 638,622 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,138,686 | 133,806 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,001,075 | 97,953 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $591,359 | 107,913 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $318,321 | 84,213 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $406,547 | 60,679 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $648,432 | 99,606 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $760,992 | 89,214 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $296,178 | 56,095 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,007,452 | 237,607 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,354,673 | 385,947 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $9,263,457 | 1,390,910 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,374,233 | 638,701 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $408,489 | 13,224 | Shares | Defined | 2021-08-23 | |
| 2020-12-31 | $109,594 | 2,365 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||